Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bexlosteride SCHEMBL7194610 | 1.00 | SRD5A1 (1.00) | SRD5A1SRD5A2 | |
| Bexlosteride SCHEMBL13735634 | 1.00 | SRD5A1 (1.00) | SRD5A1SRD5A2 | |
| Bexlosteride SCHEMBL225679 | 1.00 | SRD5A1 (1.00) | SRD5A1SRD5A2 | |
| Bexlosteride SCHEMBL7798944 | 1.00 | SRD5A1 (1.00) | SRD5A1SRD5A2 | |
| Bexlosteride SCHEMBL225678 | 1.00 | SRD5A1 (1.00) | SRD5A1SRD5A2 | |
| SCHEMBL7798977 | 0.89 | SRD5A1 (0.80) | SRD5A1SRD5A2 | |
| SCHEMBL7798978 | 0.89 | SRD5A1 (0.80) | SRD5A1SRD5A2 | |
| SCHEMBL7798956 | 0.84 | SRD5A1 (1.00) | SRD5A1SRD5A2 | |
| SCHEMBL7796416 | 0.84 | SRD5A1 (1.00) | SRD5A1SRD5A2 | |
| SCHEMBL7796411 | 0.84 | SRD5A1 (1.00) | SRD5A1SRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4447954-A1 | HETEROCYCLIC COMPOUNDS AS 5HT2A BIASED AGONISTS | Icahn School of Medicine at Mount Sinai (US) | 2024-10-23 | — | — | EP | disclosed |
| EP-4448510-A1 | INHIBITORS OF MET KINASE | Kinnate Biopharma Inc. (US) | 2024-10-23 | — | — | EP | disclosed |
| EP-4308115-A1 | HETEROAROYL AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | Merck Sharp & Dohme LLC (US) | 2024-01-24 | — | — | EP | disclosed |
| WO-2023114809-A1 | INHIBITORS OF MET KINASE | KINNATE BIOPHARMA INC. (US) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023114472-A1 | HETEROCYCLIC COMPOUNDS AS 5HT2A BIASED AGONISTS | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2023-06-22 | — | — | WO | disclosed |
| WO-2022203930-A1 | FLUOROGENIC CYANINE CARBAMATES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-09-29 | — | — | WO | disclosed |
| WO-2022197577-A1 | HETEROAROYL AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | MERCK SHARP & DOHME LLC (US) | 2022-09-22 | — | — | WO | disclosed |
| WO-2022076735-A1 | INHIBITORS OF THE BROMODOMAIN PHD FINGER TRANSCRIPTION FACTOR (BPTF) AS ANTI-CANCER AGENTS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2022-04-14 | — | — | WO | disclosed |